These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4551793)

  • 61. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
    Bonnecaze AK
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
    [No Abstract]   [Full Text] [Related]  

  • 63. [The place of Raynaud's phenomenon in arterial diseases of the upper limb].
    van der Stricht J; Goldstein M; Dereume JP
    Schweiz Rundsch Med Prax; 1976 Nov; 65(44):1365-7. PubMed ID: 1005331
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late onset Raynaud's phenomenon, hypertension, deteriorating renal function, and a fit in a middle aged woman.
    Hutchinson D; Moots RJ
    Postgrad Med J; 2001 Dec; 77(914):E10. PubMed ID: 11723338
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis.
    Lekakis J; Papamichael C; Mavrikakis M; Voutsas A; Stamatelopoulos S
    Am J Cardiol; 1998 Dec; 82(12):1555-7, A8. PubMed ID: 9874070
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Heart lesions in progressive systemic sclerosis. Intramyocardial Raynaud's phenomenon].
    Frandsen NE
    Ugeskr Laeger; 1980 May; 142(22):1423-4. PubMed ID: 7404748
    [No Abstract]   [Full Text] [Related]  

  • 68. Progressive systemic sclerosis presenting with Raynaud's phenomenon in the tongue and sensory trigeminal neuropathy.
    Casey EB; Lawton NF
    Rheumatol Phys Med; 1971 Aug; 11(3):131-3. PubMed ID: 5572022
    [No Abstract]   [Full Text] [Related]  

  • 69. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
    Yamane K
    Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.
    Kumar N; Griffiths B; Allen J
    J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964
    [No Abstract]   [Full Text] [Related]  

  • 71. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma].
    Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C
    Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: Raynaud's disease and systemic sclerosis.
    Rowell NR
    Br Med J; 1973 Nov; 4(5890):493. PubMed ID: 4758478
    [No Abstract]   [Full Text] [Related]  

  • 73. Increased pulmonary artery pressure in association with Raynaud's phenomenon.
    Ohar JM; Robichaud AM; Fowler AA; Glauser FL
    Am J Med; 1986 Aug; 81(2):361-2. PubMed ID: 3740093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
    Lau CS; Belch JJ; Madhok R; Cappell H; Herrick A; Jayson M; Thompson JM
    Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sclerodermic acrosyndromes].
    Carpentier PH
    Rev Prat; 2002 Nov; 52(17):1891-5. PubMed ID: 12532865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.
    Watson HR; Robb R; Belcher G; Belch JJ
    J Rheumatol; 1999 Aug; 26(8):1734-7. PubMed ID: 10451070
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of systemic sclerosis.
    Pope J
    Curr Opin Rheumatol; 1993 Nov; 5(6):792-801. PubMed ID: 7509616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.